$2.77 Billion is the total value of HealthCor Management, L.P.'s 39 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BDX | Exit | BECTON DICKINSON & CO | $0 | – | -24,560 | -100.0% | -0.21% | – |
DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -78,982 | -100.0% | -0.36% | – |
JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -525,000 | -100.0% | -0.53% | – |
CI | Exit | CIGNA CORPORATION | $0 | – | -100,720 | -100.0% | -0.68% | – |
AKRXQ | Exit | AKORN INC | $0 | – | -650,000 | -100.0% | -0.72% | – |
BCR | Exit | BARD C R INC | $0 | – | -76,560 | -100.0% | -0.87% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -225,000 | -100.0% | -0.88% | – |
MEDP | Exit | MEDPACE HLDGS INC | $0 | – | -700,000 | -100.0% | -0.96% | – |
ALR | Exit | ALERE INC | $0 | – | -725,000 | -100.0% | -1.32% | – |
HCA | Exit | HCA HOLDINGS INC | $0 | – | -325,000 | -100.0% | -1.33% | – |
MON | Exit | MONSANTO CO NEW | $0 | – | -300,000 | -100.0% | -1.56% | – |
QGEN | Exit | QIAGEN NV | $0 | – | -1,750,000 | -100.0% | -2.33% | – |
ALGN | Exit | ALIGN TECHNOLOGY INC | $0 | – | -525,000 | -100.0% | -2.76% | – |
INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -1,700,000 | -100.0% | -3.58% | – |
MRK | Exit | MERCK & CO INC | $0 | – | -1,475,000 | -100.0% | -4.30% | – |
ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -950,000 | -100.0% | -5.28% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
HUMANA INC | 22 | Q3 2022 | 6.6% |
BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
BIOGEN INC | 21 | Q3 2022 | 8.5% |
LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2023-05-26 |
4 | 2023-05-26 |
SC 13D/A | 2023-05-26 |
4 | 2023-04-04 |
4 | 2023-04-04 |
SC 13D/A | 2023-04-03 |
13F-HR | 2023-02-15 |
SC 13G/A | 2023-02-14 |
4 | 2023-01-04 |
4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.